FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to eye diseases and can be used for cataract treatment. That is ensured by surgical management, namely phacoemulsification. That is followed by the parabulbar introduction of the preparation Cortexin and magnetic laser stimulation of the retina and optic nerve.
EFFECT: method allows to ensure preservation and improvement of visual functions by restoring transparency of optical mediums, neuroprotective action of the preparation and a stimulating effect of magnetic laser radiation on the retina.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING DYSTROPHIC DISEASES OF EYES | 2000 |
|
RU2195297C2 |
| METHOD FOR TREATMENT OF CATARACT IN PATIENTS WITH ACTIVE NEOVASCULAR DISEASES OF MACULA | 2017 |
|
RU2659144C1 |
| METHOD FOR TREATING GLAUCOMATOUS NEUROPATHY | 2006 |
|
RU2308916C1 |
| METHOD FOR SURGICAL MANAGEMENT OF MACULAR OEDEMA FOLLOWING CATARACT PHACOEMULSIFICATION | 2010 |
|
RU2453297C2 |
| AGENT RECOVERING RETINA EYE FUNCTION | 1993 |
|
RU2073518C1 |
| METHOD FOR TREATING DIABETIC RETINOPATHY | 1999 |
|
RU2157154C1 |
| METHOD FOR MACULAR AREA MORPHOMETRIC CHANGES TREATMENT IN CASE OF POLYMORBIDE SOMATIC CONDITIONS | 2016 |
|
RU2622759C1 |
| METHOD FOR COMBINED SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY AND CATARACT | 2024 |
|
RU2826424C1 |
| METHOD FOR PHACOEMULSIFICATION IN FLOPPY IRIS SYNDROME | 2014 |
|
RU2561002C1 |
| METHOD OF TREATING VISUAL NERVE AND RETINAL DISEASES | 2010 |
|
RU2447864C1 |
